
08 Aug EDOARDO NEGRONI, MBA
– 20 years in BioPharma, Medical Devices and Consulting with different management roles in various European countries. Managed staff over 100 employees with turnover over 30M€
– CEO Inorgen (Drug Discovery Engine), UK and Italy
– Deployment of the business model, marketing with pharma companies, VCs and relevant stakeholders for partnering activities
– Agreement with a Drug Discovery company for asset co-development
– Mentoring of two academic early stage projects oncology concerning tumor microenvironment and precision medicine
– Member of the start-up commission at Tor Vergata University in Rome
– CBO International Operations OPIS (Clinical CRO), Italy
– Launched the expansion of international operations
– VP Strategy and Organization La-ser Europe, UK. Pharma Consulting in health science
– CBO Northern and Southern Europe, France
– Country Manager Italy Stallergenes, Italy
– Hit regularly sales and EBIT targets
– Built and managed successful pharma operations teams in Italy, Spain, The Netherlands and other countries
– 1 drug (Oralair) brought to market in Italy and Spain
– Rationalisation of the drug of named patient products portfolio (from 150+ to 10 products) to follow a specialty medicine’s pharmaceutical approach
– Sales and Marketing Director, Air Liquide Medical Systems, Italy
– Various management roles in industry, France and Italy
Sorry, the comment form is closed at this time.